{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "20427188",
  "DateCompleted": {
    "Year": "2010",
    "Month": "11",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2010",
    "Month": "05",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2010",
        "Month": "04",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jocn.2009.10.040"
    ],
    "Journal": {
      "ISSN": "1532-2653",
      "JournalIssue": {
        "Volume": "17",
        "Issue": "7",
        "PubDate": {
          "Year": "2010",
          "Month": "Jul"
        }
      },
      "Title": "Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia",
      "ISOAbbreviation": "J Clin Neurosci"
    },
    "ArticleTitle": "Oncomodulatory mechanisms of human cytomegalovirus in gliomas.",
    "Pagination": {
      "StartPage": "819",
      "EndPage": "823",
      "MedlinePgn": "819-23"
    },
    "Abstract": {
      "AbstractText": [
        "Human cytomegalovirus (HCMV), a widespread beta-herpes virus, infects a high percentage of high grade gliomas. Although HCMV is not recognized as an oncogenic virus, it might increase the malignancy of the infected cell by disrupting cellular pathways involved in the cell cycle, apoptosis, angiogenesis, cell invasion and the host immune response. This article reviews the recent evidence of the modulatory effects of HCMV infection leading to the malignant progression of gliomas and explores novel therapeutic targets against such lethal tumors."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Memorial Neuroscience Center, Memorial Hospital Jacksonville, Suite 355, Jacksonville, Florida 32216, USA. kbarami@yahoo.com"
          }
        ],
        "LastName": "Barami",
        "ForeName": "Kaveh",
        "Initials": "K"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Scotland",
    "MedlineTA": "J Clin Neurosci",
    "NlmUniqueID": "9433352",
    "ISSNLinking": "0967-5868"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Cell Cycle"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Cell Movement"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "Cytomegalovirus"
    },
    {
      "QualifierName": [
        "drug therapy",
        "pathology",
        "virology"
      ],
      "DescriptorName": "Cytomegalovirus Infections"
    },
    {
      "QualifierName": [
        "drug therapy",
        "pathology",
        "virology"
      ],
      "DescriptorName": "Glioma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    }
  ],
  "NumberOfReferences": "64"
}